Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study
Titel:
Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study
Auteur:
Thuss-Patience, Peter C Shah, Manish A Ohtsu, Atsushi Van Cutsem, Eric Ajani, Jaffer A Castro, Hugo Mansoor, Wasat Chung, Hyun Cheol Bodoky, Gyorgy Shitara, Kohei Phillips, Gail D Lewis van der Horst, Tina Harle-Yge, Marie-Laurence Althaus, Betsy L Kang, Yoon-Koo